ITEMS IN AFP WITH KEYWORD:

Asthma

Nov 15, 2019 Issue
As-Needed Budesonide/Formoterol Similar to Maintenance Budesonide Plus SABA in Patients with Mild Asthma [POEMs]

In these patients with mild asthma (more than one-half used a short-acting beta-agonist [SABA] such as albuterol two or fewer times per week), as-needed use of a combined budesonide/formoterol (Symbicort) inhaler was as effective at preventing exacerbations as daily maintenance budesonide (Pulmicort...


Aug 15, 2019 Issue
Asthma, Back and Neck Pain, Pain During Labor, TIA, CBT for Anxiety [AFP Clinical Answers]

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.


Aug 1, 2019 Issue
More Evidence Against Antibiotics for Acute Asthma Exacerbations [POEMs]

Antibiotics do not benefit patients hospitalized with an asthma exacerbation. Evidence from this study suggests worse outcomes with antibiotic use, including a longer hospital stay, higher costs, and greater risk of diarrhea.


Aug 1, 2019 Issue
Asthma, PAD and Cardiovascular Disease, Persons Who Inject Drugs, Crohn’s Disease, Insulin Analogs [AFP Clinical Answers]

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.


Mar 15, 2019 Issue
Osteoporosis, Childhood Bullying, Rheumatoid Arthritis, Diabetes Counseling, Inhaled Steroids [AFP Clinical Answers]

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.


Jan 15, 2019 Issue
Intravenous Magnesium Sulfate for Acute Asthma Exacerbations [FPIN's Clinical Inquiries]

Patients presenting to the emergency department with an acute asthma exacerbation that has not responded to first-line therapy (bronchodilators and corticosteroids) can be treated effectively with intravenous magnesium sulfate.


Jan 1, 2019 Issue
LABA Plus Inhaled Corticosteroid Reduces Exacerbations, But Not Hospitalizations [POEMs]

Adding a LABA to an inhaled corticosteroid is safe but does not reduce the likelihood of a serious exacerbation requiring hospitalization. There is a small reduction in nonsevere asthma exacerbations, with one fewer exacerbation for every 53 patients treated for six months.


Nov 15, 2018 Issue
As-Needed Use of Budesonide Plus Formoterol As Good As Daily Use of Steroid [POEMs]

As-needed use of budesonide/formoterol is as effective as the daily use of maintenance budesonide plus as-needed terbutaline at preventing severe exacerbations, and results in a much lower cumulative steroid dose.


Nov 1, 2018 Issue
Culture-Specific Asthma Education Programs for Minority Groups [Cochrane for Clinicians]

In children from minority groups, culture-specific asthma education programs (CAEPs) reduce the number of severe asthma exacerbations requiring hospitalization and improve asthma control as measured by the Childhood Asthma Control Test but not the Asthma Control Questionnaire. CAEPs have no effect on overall asthma exacerbations in children.


Oct 15, 2018 Issue
Long-Acting Muscarinic Antagonists plus Inhaled Steroids is Equal to Long-Acting Beta-Agonists Plus Inhaled Steroids [POEMs]

Long-acting muscarinic antagonists added to inhaled corticosteroids are a superior treatment to placebo for improving asthma control in adults and children 12 years or older. Long-acting muscarinic antagonist add-on therapy is not superior to long-acting beta agonist (LABA) add-on therapy.


Pages: 1 2 3 4 5 6 7 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now